Search results
‘A study to give us hope:’ Lifestyle changes improve Alzheimer’s symptoms for some
CNN via Yahoo News· 41 minutes agoFollowing a vegan diet, reducing stress, exercising and sharing feelings with others helped people...
Changing Your Diet and Lifestyle May Slow Down Alzheimer's
Time via AOL· 12 hours ago“Those include inflammation, overstimulation of the sympathetic nervous system, changes in the...
Rare disease's mutation could explain more common conditions
Medical Xpress· 3 days agoTREX1 is a gene that is supposed to direct the maintenance of the entire body's DNA, but new...
UCLA Health Study Connects Genetic Risk for Autism to Changes Observed in the Brain
Sierra Sun Times· 24 hours agoBy Will Houston - A new study led by UCLA researchers has unveiled the most detailed view of the complex biological mechanisms underlying autism, showing the first link between genetic risk ...
So Long, Brain Fog! Here Are the 11 Best Foods to Keep Your Mind In Tip-Top Shape
Parade via AOL· 3 days ago“Omega-3 fats, and vitamins C and K are just some of the nutrients in kale that aid in full-body...
Ultrasound device implanted in skull may help target brain tumors - UPI.com
UPI· 21 hours agoNew research shows that ultrasound waves emitted from a device implanted in a cancer patient's skull...
Children with total deafness regain hearing after ‘groundbreaking’ gene therapy: ‘Like a miracle’
Fox News via Yahoo News· 2 days agoFive children who were born completely deaf have had their hearing loss reversed after receiving a...
Halsey reveals she has lupus and a rare blood-cell disorder. Here's what to know.
Yahoo Life Style via AOL· 13 hours agoLupus inflammation can also cause arthritis, or painful swelling of the joints. General achiness,...
'Whole family cried': New gene therapy offers hope for deaf kids
Alaska Superstation· 2 days agoZhu Yangyang babbles away like a typical happy three-year-old, calling out for "mama" and "papa" and...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug By Reuters
Investing.com· 24 hours agoThe drug is a potential rival to Eisai and Biogen (NASDAQ:BIIB)'s Leqembi, which won approval last July. Both treatments are antibodies designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer's disease.